A carregar...
Real-world experience with pembrolizumab toxicities in advanced melanoma patients: a single-center experience in the UK
AIM: We aimed to characterize the safety profile of pembrolizumab in advanced melanoma patients at our center to better reflect ‘real-world’ data on anti-PD-1 inhibitors. MATERIALS & METHODS: At our institution, 58 ipilimumab-naive and 30 ipilimumab-treated patients with advanced melanoma who ha...
Na minha lista:
| Publicado no: | Melanoma Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6122523/ https://ncbi.nlm.nih.gov/pubmed/30190931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2017-0028 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|